vs
Side-by-side financial comparison of REGIS CORP (RGS) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
Vanda Pharmaceuticals Inc. is the larger business by last-quarter revenue ($57.2M vs $57.1M, roughly 1.0× REGIS CORP). REGIS CORP runs the higher net margin — 0.8% vs -246.8%, a 247.6% gap on every dollar of revenue. On growth, REGIS CORP posted the faster year-over-year revenue change (22.3% vs 7.6%). REGIS CORP produced more free cash flow last quarter ($891.0K vs $-29.5M). Over the past eight quarters, Vanda Pharmaceuticals Inc.'s revenue compounded faster (9.8% CAGR vs 7.8%).
REGIS CORPRGSEarnings & Financial Report
Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
RGS vs VNDA — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $57.1M | $57.2M |
| Net Profit | $456.0K | $-141.2M |
| Gross Margin | — | — |
| Operating Margin | 10.8% | -70.5% |
| Net Margin | 0.8% | -246.8% |
| Revenue YoY | 22.3% | 7.6% |
| Net Profit YoY | -94.0% | -2774.3% |
| EPS (diluted) | $0.16 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $57.1M | $57.2M | ||
| Q3 25 | $59.0M | $56.3M | ||
| Q2 25 | $60.4M | $52.6M | ||
| Q1 25 | $57.0M | $50.0M | ||
| Q4 24 | $46.7M | $53.2M | ||
| Q3 24 | $46.1M | $47.7M | ||
| Q2 24 | $49.4M | $50.5M | ||
| Q1 24 | $49.2M | $47.5M |
| Q4 25 | $456.0K | $-141.2M | ||
| Q3 25 | $1.4M | $-22.6M | ||
| Q2 25 | $116.5M | $-27.2M | ||
| Q1 25 | $250.0K | $-29.5M | ||
| Q4 24 | $7.6M | $-4.9M | ||
| Q3 24 | $-853.0K | $-5.3M | ||
| Q2 24 | $91.2M | $-4.5M | ||
| Q1 24 | $-2.3M | $-4.1M |
| Q4 25 | 10.8% | -70.5% | ||
| Q3 25 | 10.0% | -55.6% | ||
| Q2 25 | 12.1% | -73.2% | ||
| Q1 25 | 8.8% | -82.0% | ||
| Q4 24 | 11.8% | -19.3% | ||
| Q3 24 | 4.6% | -23.1% | ||
| Q2 24 | — | -20.1% | ||
| Q1 24 | 8.3% | -19.5% |
| Q4 25 | 0.8% | -246.8% | ||
| Q3 25 | 2.3% | -40.1% | ||
| Q2 25 | 192.9% | -51.7% | ||
| Q1 25 | 0.4% | -58.9% | ||
| Q4 24 | 16.4% | -9.2% | ||
| Q3 24 | -1.9% | -11.2% | ||
| Q2 24 | 184.7% | -9.0% | ||
| Q1 24 | -4.7% | -8.7% |
| Q4 25 | $0.16 | $-2.40 | ||
| Q3 25 | $0.49 | $-0.38 | ||
| Q2 25 | $43.67 | $-0.46 | ||
| Q1 25 | $0.08 | $-0.50 | ||
| Q4 24 | $2.71 | $-0.09 | ||
| Q3 24 | $-0.36 | $-0.09 | ||
| Q2 24 | $38.40 | $-0.08 | ||
| Q1 24 | $-1.00 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.4M | $84.9M |
| Total DebtLower is stronger | $113.3M | — |
| Stockholders' EquityBook value | $188.7M | $327.2M |
| Total Assets | $588.3M | $488.9M |
| Debt / EquityLower = less leverage | 0.60× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.4M | $84.9M | ||
| Q3 25 | $16.6M | $70.0M | ||
| Q2 25 | $17.0M | $81.0M | ||
| Q1 25 | $13.3M | $111.8M | ||
| Q4 24 | $10.2M | $102.3M | ||
| Q3 24 | $6.3M | $100.5M | ||
| Q2 24 | $10.1M | $103.0M | ||
| Q1 24 | $5.9M | $125.2M |
| Q4 25 | $113.3M | — | ||
| Q3 25 | $111.3M | — | ||
| Q2 25 | $110.8M | — | ||
| Q1 25 | $112.0M | — | ||
| Q4 24 | $111.5M | — | ||
| Q3 24 | $95.2M | — | ||
| Q2 24 | $99.5M | — | ||
| Q1 24 | $179.7M | — |
| Q4 25 | $188.7M | $327.2M | ||
| Q3 25 | $187.6M | $466.0M | ||
| Q2 25 | $185.6M | $486.3M | ||
| Q1 25 | $68.6M | $511.4M | ||
| Q4 24 | $66.7M | $538.5M | ||
| Q3 24 | $56.4M | $541.2M | ||
| Q2 24 | $56.8M | $542.5M | ||
| Q1 24 | $-35.8M | $544.0M |
| Q4 25 | $588.3M | $488.9M | ||
| Q3 25 | $592.1M | $601.1M | ||
| Q2 25 | $599.0M | $624.7M | ||
| Q1 25 | $511.2M | $631.9M | ||
| Q4 24 | $530.1M | $656.2M | ||
| Q3 24 | $508.9M | $645.1M | ||
| Q2 24 | $530.5M | $651.4M | ||
| Q1 24 | $543.7M | $652.7M |
| Q4 25 | 0.60× | — | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.60× | — | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 1.67× | — | ||
| Q3 24 | 1.69× | — | ||
| Q2 24 | 1.75× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.7M | $-29.4M |
| Free Cash FlowOCF − Capex | $891.0K | $-29.5M |
| FCF MarginFCF / Revenue | 1.6% | -51.6% |
| Capex IntensityCapex / Revenue | 1.4% | 0.2% |
| Cash ConversionOCF / Net Profit | 3.65× | — |
| TTM Free Cash FlowTrailing 4 quarters | $14.9M | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $-29.4M | ||
| Q3 25 | $2.3M | $-31.6M | ||
| Q2 25 | $6.8M | $-15.3M | ||
| Q1 25 | $6.2M | $-33.1M | ||
| Q4 24 | $2.1M | $-1.8M | ||
| Q3 24 | $-1.3M | $-14.6M | ||
| Q2 24 | $5.1M | $-6.9M | ||
| Q1 24 | $-277.0K | $7.6M |
| Q4 25 | $891.0K | $-29.5M | ||
| Q3 25 | $1.9M | $-31.8M | ||
| Q2 25 | $6.2M | $-15.6M | ||
| Q1 25 | $5.9M | $-33.6M | ||
| Q4 24 | $1.7M | $-2.0M | ||
| Q3 24 | $-1.4M | $-14.7M | ||
| Q2 24 | $5.1M | $-7.0M | ||
| Q1 24 | $-326.0K | $7.6M |
| Q4 25 | 1.6% | -51.6% | ||
| Q3 25 | 3.2% | -56.5% | ||
| Q2 25 | 10.3% | -29.6% | ||
| Q1 25 | 10.3% | -67.1% | ||
| Q4 24 | 3.6% | -3.8% | ||
| Q3 24 | -3.0% | -30.9% | ||
| Q2 24 | 10.3% | -13.9% | ||
| Q1 24 | -0.7% | 15.9% |
| Q4 25 | 1.4% | 0.2% | ||
| Q3 25 | 0.7% | 0.3% | ||
| Q2 25 | 0.9% | 0.6% | ||
| Q1 25 | 0.6% | 0.9% | ||
| Q4 24 | 0.9% | 0.4% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.0% | 0.2% | ||
| Q1 24 | 0.1% | 0.0% |
| Q4 25 | 3.65× | — | ||
| Q3 25 | 1.68× | — | ||
| Q2 25 | 0.06× | — | ||
| Q1 25 | 24.80× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.06× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
